
Henry Schein, Inc.
HSICNASDAQHealthcareMedical - Distribution
Previous close
$88.50
+$0.04 · +0.05%
HSIC company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
71
Undervalued
Momentum
53
Neutral
Sentiment
63
Bullish
Risk resilience
80
Low Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteHenry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Frederick Lowery
- Listed since
- Nov 3, 1995
- Employees
- 25,000
Market position
Day range
Current $88.50
52-week range
Current $88.50
- Open
- $88.74
- Previous close
- $88.46
- Volume
- 758.82K
- 0.53× average
- Average volume
- 1.42M
- Average daily volume
- Market cap
- 10.08B USD
- Beta
- 0.81
- Market reference 1
- 50-day average
- $85.6386
- +3.34% above average
- 200-day average
- $78.194
- +13.18% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 12.73B USD
- EV / EBITDA
- 12.65×
- Earnings yield
- 4.33%
- Free cash flow yield
- 6.23%
Profitability & efficiency
- Return on equity
- 12.27%
- Return on assets
- 3.55%
- Return on invested capital
- 6.58%
Financial health
- Current ratio
- 1.38×
- Altman Z-score
- 2.82
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.18B USD | 12.67B USD | 12.34B USD | 12.65B USD | 12.4B USD |
| Cost of goods sold | 9.34B USD | 8.91B USD | 8.69B USD | 9B USD | 8.73B USD |
| Gross profit | 3.84B USD | 3.77B USD | 3.65B USD | 3.65B USD | 3.67B USD |
| Selling, general, and administrative | 3.08B USD | 3.04B USD | 2.94B USD | 2.71B USD | 2.82B USD |
| Operating expenses | 3.08B USD | 3.04B USD | 2.94B USD | 2.71B USD | 2.82B USD |
| Interest income | 33M USD | 24M USD | 17M USD | 17M USD | 6.45M USD |
| Interest expense | 150M USD | 131M USD | 87M USD | 44M USD | 27.6M USD |
| Depreciation and amortization | 311M USD | 297M USD | 248M USD | 212M USD | 209.53M USD |
| Operating income | 758M USD | 729M USD | 714M USD | 938M USD | 854.81M USD |
| Net income | 398M USD | 390M USD | 416M USD | 538M USD | 623.91M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 73%
- 8 beats, 3 misses, 0 met estimates
- Average EPS surprise
- +2.35%
- 11 comparable reports
- Latest EPS result
- 1.27
- Estimate 1.24 · Beat by 2.42%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$91.80
3.73% upsideRecent analyst actions
HSIC news
HSIC peers
Continue in GoAI
Research HSICresearch.disclaimer











